Selective expression of TGF-β2 and TGF-β3 isoforms in early mesangioproliferative glomerulonephritis

Nephron - Experimental Nephrology

Volumn 96, Issue 4, 2004, Pages

  Minto, Andrew W ^a   Wilson, Heather M ^b   Rees, Andrew J ^b   Quigg, Richard J ^a   Brown, Paul A J ^b  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Mesangioproliferative glomerulonephritis; TGF isoforms; Thy 1 nephritis

Indexed keywords

CANCER GROWTH FACTOR; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY OX 7; THY 1 ANTIGEN; TUMOR GROWTH FACTOR BETA1; TUMOR GROWTH FACTOR BETA2; TUMOR GROWTH FACTOR BETA3; UNCLASSIFIED DRUG; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; DIFFUSION; DISEASE COURSE; EPITHELIUM CELL; EXPERIMENTAL MODEL; GLOMERULUS; INJECTION; MACROPHAGE; MALE; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STAINING;

ACUTE DISEASE; ANIMALS; CELL MOVEMENT; DISEASE PROGRESSION; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION; GLOMERULONEPHRITIS, MEMBRANOPROLIFERATIVE; LEUKOCYTES; MALE; PROTEIN ISOFORMS; RATS; RATS, INBRED LEW; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3;

EID: 2342562545     PISSN: 16602129     EISSN: None     Source Type: Journal    
DOI: 10.1159/000077377     Document Type: Article

References (33)

1. Border WA, Noble NA: Cytokines in kidney disease: the role of transforming growth factor-β. Am J Kidney Dis 1993;22:105-113.
2. Border WA, Noble NA: Transforming growth factor-β in tissue fibrosis. N Engl J Med 1994;331:1286-1292.
3. Yamamoto Y, Noble NA, Miller DE, et al: Sustained expression of TGF-β1 underlies development of progressive kidney fibrosis. Kidney Int 1994;45:916-927.
4. Yamamoto T, Noble NA, Cohen AH, et al: Transforming growth factor-β isoforms in human glomerular diseases. Kidney Int 1996;49:461-469.
5. Ohta M, Greenberger JS, Anklesaria P, et al: Two forms of transforming growth factor beta distinguished by multipotential haematopoietic progenitor cells. Nature 1987;329:539-541.
6. Massagué J: Receptors for the TGF-β family. Cell 1990;69:1067-1070.
7. Letterio JJ, Roberts AB: Regulation of immune responses by TGF-β. Annu Rev Immunol 1998;16:137-161.
8. Shah M, Foreman DM, Ferguson MW: Neutralization of TGF-β1 and TGF-β2 or exogenous addition of TGF-β3 to cutaneous rat wounds reduces scarring. J Cell Sci 1995;108:985-1002.
9. Milani S, Herbst H, Schuppan D, et al: Transforming growth factors beta 1 and beta 2 are differentially expressed in fibrotic liver disease. Am J Pathol 1991;139:1221-1229.
10. Kaartinen V, Voncken JW, Shuler C, et al: Abnormal lung development and cleft palate in mice lacking TGF-β3 indicates defects of epithelial-mesenchymal interaction. Nat Genet 1995;11:415-421.
11. Luo K, Lodish HF: Positive and negative regulation of type II TGF-β receptor signal transduction by autophosphorylation on multiple serine residues. EMBO J 1997;16:1970-1981.
12. Roberts AB, Sporn MB: The transforming growth factor betas; in Sporn MB, Roberts AB (eds): Peptide Growth Factors and Their Receptors. Berlin, Springer, 1990, pp 419-472.
13. Kitamura M, Mitarai T, Maruyama N, et al: Mesangial cell behaviour in a three-dimensional extracellular matrix. Kidney Int 1991;40:653-661.
14. Nakamura T, Okuda S, Ruoslahti E, et al: Production of extracellular matrix by glomerular epithelial cells is regulated by transforming growth factor-β1. Kidney Int 1992;37:689-695.
15. Baricos WH, Cortez SL, El-Dahr SS, et al: ECM degradation by cultured human mesangial cells is mediated by a PAI/plasmin/MMP-2 cascade. Kidney Int 1995;47:1039-1047.
16. Floege J, Johnson RJ, Gordon KL, et al: Increased synthesis of extracellular matrix in mesangial proliferative nephritis. Kidney Int 1991;40:477-488.
17. Okuda S, Languino LR, Ruoslahti E, et al: Elevated expression of TGF-β and proteoglycan production in experimental glomerulonephritis. J Clin Invest 1990;86:453-462.
18. Sedor JR: Cytokines and growth factors in renal injury. Semin Nephrol 1992;12:428-440.
19. Stewart KN, Wilson PJ, Minto AW, et al: Agerelated glomerulosclerosis in Thy-1 glomerulonephritis. Nephron 2001;88:57-64.
20. Morita H, Maeda K, Obayashi T, et al: Induction of irreversible glomerulosclerosis in the rat by repeated injections of a monoclonal anti-Thy-1.1 antibody. Nephron 1992;60:92-99.
21. Bradley GM, Benson ES: Examination of the urine; in Davidson I, Henry JB (eds): Todd-Sanford Clinical Diagnosis by Laboratory Methods. Philadelphia, Saunders, 1974, p 74.
22. Border WA, Okuda S, Languino LR, et al: Suppression of experimental glomerulonephritis by antiserum against transforming growth factor-β1. Nature 1990;346:371-374.
23. Border WA, Noble NA: TGF-β in kidney fibrosis: A target for gene therapy. Kidney Int 1997;51:1388-1396.
24. Mozes MM, Bottinger EP, Jacot TA, et al: Renal expression of fibrotic matrix proteins and of transforming growth factor-β (TGF-β) isoforms in TGF-β transgenic mice. J Am Soc Nephrol 1999;10:271-280.
25. Opperman LA, Nolen AA, Ogler C: TGF-β1, TGF-β2, and TGF-β3 exhibit distinct patterns of expression during cranial suture formation and obliteration in vivo and in vitro. J Bone Miner Res 1997;12:301-310.
26. Shah M, Foreman DM, Ferguson WJ: Neutralization of TGF-β1 and TGF-β2 or exogenous addition of TGF-β3 to cutaneous rat wounds reduces scarring. J Cell Sci 1995;108:985-1002.
27. Murata H, Zhou L, Ochoa S, et al: TGF-β3 stimulates and regulates collagen synthesis through TGF-β1-dependent and independent mechanisms. J Invest Dermatol 1997;108:258-262.
28. Nakayama M, Okuda S, Tamaki K, et al: Roles of TGF-β and latent TGF-β-binding protein in glomerulosclerosis induced by two consecutive injections of monoclonal antibody 1-22-3 in rats. Nephron 1997;76:82-89.
29. Ito Y, Goldschmeding R, Bende RJ, et al: Kinetics of connective tissue growth factor expression during experimental proliferative glomerulonephritis. J Am Soc Nephrol 2001;12:472-484.
30. Phillips AO, Steadman R, Topley N, et al: Elevated D-glucose concentrations modulate TGF-β1 synthesis by human cultured renal proximal tubular cells: The permissive role of platelet-derived growth factor. Am J Pathol 1995;147:362-374.
31. Shankland SJ, Pippin J, Pichler RH, et al: Differential expression of transforming growth factor-β isoforms and receptors in experimental membranous nephrophathy. Kidney Int 1996;50:116-124.
32. Soulis-Liparota T, Cooper M, Papazoglou D, et al: Retardation by aminoguanidine of development of albuminuria, mesangial expansion, and tissue fluorescence in streptozotocin-induced diabetic rat. Diabetes 1991;40:1328-1334.
33. Shankland SJ, Scholey JW, Ly H, et al: Expression of transforming growth factor-β1 during diabetic renal hypertrophy. Kidney Int 1994;46:430-442.